Thats a 70-100 fold increase at comparable weight loss velocities
Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L
Conclusion If you're waiting for retatrutide, the realistic timeline is late 2027 to mid-2028 for FDA approval and commercial launch
Retatrutide works by mimicking the action of three naturally occurring hormone pathways involved in appetite, digestion, blood sugar control and energy balance
Clinical trial participation, identified via the NIHR 'Be Part of Research' portal, ClinicalTrials.gov, or the ISRCTN registry, is the only currently regulated access route in the UK
GLP-1 medications work by mimicking a hormone involved in appetite, fullness, and blood sugar regulation